Palvella Therapeutics PVLA Change in fair value of interest rate swap
Change in fair value of interest rate swap at other companies
Other financials
Where this comes from
Reported directly by Palvella Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:UnrealizedGainLossOnDerivatives.
The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Palvella Therapeutics's change in fair value of interest rate swap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Palvella Therapeutics's change in fair value of interest rate swap?
- Palvella Therapeutics (PVLA) reported change in fair value of interest rate swap of -$116K in Q1 2026.
- How has Palvella Therapeutics's change in fair value of interest rate swap changed year-over-year?
- Palvella Therapeutics's change in fair value of interest rate swap decreased by 54.7% year-over-year, from -$75K to -$116K.
- What does change in fair value of interest rate swap mean?
- This reflects the change in the market value of derivative financial instruments that have not yet been settled. It captures non-cash fluctuations in value resulting from market volatility in interest rates, currencies, or other underlying assets. Monitoring this helps investors understand the impact of hedging activities on the company's bottom line.